Zobrazeno 1 - 10 of 33 pro vyhledávání: '"Vanessa C. Williams"'
1
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study
Autor: Mario Petrini, Christian H. Geisler, Marinus H. J. van Oers, Steen Lisby, Mark-David Levin, Kazimierz Kuliczkowski, Sebastian Grosicki, Ira Gupta, Lukas Smolej, Stephanie Manson, Fritz Offner, Vanessa C. Williams, Jennifer Phillips
Publikováno v: lancet oncology, 16(13), 1370-1379. Lancet Publishing Group
Ofatumumab is a human anti-CD20 monoclonal antibody that has proven efficacy as monotherapy in refractory chronic lymphocytic leukaemia. We assessed the efficacy and safety of ofatumumab maintenance treatment versus observation for patients in remiss
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4abb7582a77d6f04fe5498e78d677f1
https://doi.org/10.1016/s1470-2045(15)00143-6
Zobrazit plný text záznamu
2
Trizivir (Abacavir/Lamivudine/Zidovudine) plus Lopinavir/Ritonavir Induction Therapy Followed by Trizivir-Alone Maintenance for HIV-1-Infected Patients: A 96-Week Pilot Treatment Simplification Study
Autor: Katrina L. Oie, John E. Fuchs, Dean T. Martin, Gary E. Pakes, Benjamin Daquioag, Joseph C. Gathe, Vanessa C. Williams, M. Keith Rawlings
Publikováno v: World Journal of AIDS. :245-251
Objective: The purpose of this study was to investigate whether switching HIV-infected patients stabilized on Trizivir (abacavir 300 mg/lamivudine 150 mg/zidovudine 300 mg) plus lopinavir/ritonavir 400 mg/100mg twice daily to Trizivir alone affects c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f88b02b590b697f88da1e0d5f066c919
https://doi.org/10.4236/wja.2012.23032
Zobrazit plný text záznamu
5
Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data
Autor: Belinda Ha, David Irlbeck, Edwin DeJesus, Vanessa C. Williams, Charles T Lancaster, Allan Rodriguez, Lisa L. Ross
Publikováno v: The Open AIDS Journal
In HBV/HIV-coinfected patients, the risk of end-stage liver disease and death is increased. This open-label, prospective, pilot study evaluated abacavir/lamivudine/zidovudine twice daily plus tenofovir once daily in HBV/HIV- coinfected antiretroviral
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0834eb0112ced3f56f68e5d5c582a58
http://europepmc.org/articles/PMC3023942
Zobrazit plný text záznamu
6
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma
Autor: Thomas S. Lin, Hedy Smith, Vanessa C. Williams, John P. Leonard, Thierry Horner, Stephanie A. Gregory, Patricia Giampietro
Publikováno v: Clinical lymphoma, myelomaleukemia. 16(4)
The efficacy and safety of tositumomab/iodine-131 tositumomab (TST/I-131 TST) were evaluated in diffuse large B-cell lymphoma patients who responded to first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Fifteen patients (me
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d9bae029e9d966072213888e504498c
https://pubmed.ncbi.nlm.nih.gov/26832194
Zobrazit plný text záznamu
8
Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study
Autor: Douglas J. Ward, Michael Sension, Jaime E. Hernandez, J. Tyler Lonergan, Grace A. McComsey, Vanessa C. Williams, Siegrid M. Hessenthaler, Robin L. Fisher, Peter Shalit
Publikováno v: Clinical Infectious Diseases. 38:263-270
Stavudine use is a contributing factor for lipoatrophy, whereas use of abacavir or zidovudine is less likely to cause this complication. The TARHEEL study was a 48-week, open-label study that assessed changes in lipoatrophy after abacavir (86 patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5cb3ddbcb37a349e3d27fa5346a7a6
https://doi.org/10.1086/380790
Zobrazit plný text záznamu
9
Impact of an Educational Program on Efficacy and Adherence With a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients
Autor: Jerry M. Tolson, S. Diane Goodwin, Karen H. Crawford, Mark S. Shaefer, Melanie A. Thompson, Charles Farthing, Joseph Racine, M. Keith Rawlings, Robert C. Scott, Vanessa C. Williams, Lawrence S. Brown
Publikováno v: JAIDS Journal of Acquired Immune Deficiency Syndromes. 34:174-183
A 24-week open-label clinical trial was conducted in 195 HIV-infected adults commonly underrepresented in research (35% female, 71% African American, 21% Hispanic, and 20% injection drug users [IDUs]) to evaluate the effect of an HIV educational prog
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47684976490d611502040e5f876209a
https://doi.org/10.1097/00126334-200310010-00007
Zobrazit plný text záznamu
10
Leukotriene D receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma
Autor: Jørgen Bo Rasmussen, Philip Tagari, Vanessa C. Williams, Dorothy J. Margolskee, Karl-Erik Andersson, Lars-Olof Eriksson
Publikováno v: Journal of Allergy and Clinical Immunology. 90:193-201
We have tested the hypothesis that leukotriene D 4 (LTD 4 ) receptor activation is involved in the development of antigen-induced bronchoconstriction. In two studies, patients with asthma received infusions of placebo or MAT-571, a potent and specifi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2b95238b8808df8ebe8bb0c846b8427
https://doi.org/10.1016/0091-6749(92)90071-9
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje